QBL reveals major CANNABIS product DISTRIBUTION scheme
QBL reveals major CANNABIS product DISTRIBUTION scheme
Written on the 3 April 2018 by Paris Faint
The cannabis subsidiary of Queensland Bauxite (ASX: QBL) has secured new distribution deal which could bring a new drug into the mainstream by the end of 2018.
Medical Cannabis Limited (MCL) has developed its Australian distribution strategy for the Canntab XR tablet, a drug developed by Canadian pharmaceuticals company Canntab.
Canntab XR is designed to provide pain relief to cancer patients and provide an alternative to opioid-based treatments.
While the drug is still in clinical trials, MCL expects to start importing Canntab XR during 1H18 and make it available through the government's special access scheme (SAS) soon after.
"While the SAS is currently limited in scale, the company will continue studies for broader market penetration in tandem with the SAS," said the company in a market update.
Pnina Feldman, chairperson of Queensland Bauxite, said the focus throughout 2018 will be preparing the product for market.
"We believe this product is well positioned compared to competing cannabis products and will make a lasting difference to many Australians in need," said Feldman.
"[This year] is shaping up to be a milestone year and we look forward to seeing the first revenues from our medical division shortly."
While initial revenue from Canntab XR is expected to come through the SAS, following the clinical trial phase, the company will use gathered data to market the drug to a wider segment.
MCL expects Canntab XR will attract strong interest "given the concerns of the medical industry around the safety of smoked and vaporised cannabinoids".
The announcement follows a string of major updates for Queensland Bauxite and MCL since the beginning of 2018.
In January, MCL appointed 'Amazon John' Easterling to its board of directors.
Easterling is a veteran developer of therapeutical products from plants and an experienced cultivator of medical cannabis.
In 2008, Easterling married Olivia Newton-John, another avid supporter of the industry. The duo continues to grow the Olivia Newton-John Cancer Wellness and Research Centre in Melbourne.
Just over a month following Easterling's appointment, MCL signed another landmark agreement with a research team in Israel.
MCL will sponsor the Technion Research and Development Foundation, based in Haifa, as it aims to discern the effects of medical cannabis in multiple sclerosis patients.
Under the agreement, MCL will retain an exclusive licence for any product which is derived from the research.
Here you have a opportunity to take advantage on facts and info from QBL. Like the QBL on ASX website chapter, who can provide verified facts; here is regulated on-line stockbrokers suggestion, no games info and a good sum up. Voluntary suspension is requested regarding a significant and strategic acquisition by QBL’s subsidiary Medical Cannabis Limited until thursday 17, the day after tomorrow. Contact information to the QBL Investor service, who can reply on questions. https://www.queenslandbauxite.com/
Robert
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...
Continue Reading
A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...
Continue Reading
Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...
Continue Reading
Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...
Continue Reading
Retail’s front door is quietly being moved by a machine, and plenty of big chains appear to be staring at the old entrance. Bain’s latest work lands on an uncomfortable point: owning market share does not guarantee a retailer gets named when an AI assistant answers a shopper’s question. That ought to rattle management teams more than the usual holiday-season...
Continue Reading
A Revenue Promise Hit the Wall Solar investing can turn ugly in a hurry when a supposedly near-term catalyst gets shoved down the calendar. That is the central bruise behind the securities class action involving Tigo Energy, not some arcane accounting footnote that only lawyers can love. The complaint alleges Tigo overstated the revenue contribution it expected from its...
Continue Reading
GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...
Continue Reading
A 1.8-kilogram box may not sound like much, but it captures where household solar is trying to go: smaller, less intimidating, and far easier to put to work. At RE+ 2026 in Las Vegas, Hoymiles laid out a residential lineup spanning plug-in solar, battery storage and conventional rooftop microinverters. This was not one flashy gadget looking for applause. It was a fairly...
Continue Reading
A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...
Continue Reading
GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...
Continue Reading
Top 5 Most Recently Viewed Articles
Growing Demand for Circuit Breakers in Diverse Industries The circuit breaker market is gearing up for significant growth, projected to reach a remarkable valuation of USD 9.4 billion by 2031. This exciting expansion is largely attributed to the rising demand for electricity and the escalating need for efficient and reliable energy distribution systems. A compound annual...
Continue Reading
Faruqi & Faruqi's Investigation on Behalf of Investors Faruqi & Faruqi, LLP is actively investigating potential claims for investors of MoonLake Immunotherapeutics (NASDAQ: MLTX). This initiative is aimed at supporting those who have experienced financial losses and educating them about their legal options. Investors affected are encouraged to reach out to the firm's...
Continue Reading
Golden Ocean Group Limited Reports Q2 2024 Financial Results Hamilton, Bermuda – Golden Ocean Group Limited (NASDAQ/OSE: GOGL), recognized as the largest publicly traded owner of large dry bulk vessels, has released its unaudited financial results for the quarter ending June 30, 2024. Financial Highlights In the second quarter of 2024, Golden Ocean achieved a net income...
Continue Reading
Expanding Access to Oral Health Care in Georgia Governor Signs Milestone Teledentistry Bill into Law Recently, a significant milestone for dental care was achieved with the signing of House Bill 567, aimed at enhancing access to oral health care through teledentistry. This new legislation, advanced by the Georgia Dental Association, is designed to remove barriers that...
Continue Reading
Anticipated Growth in Economic Indicators for Upcoming GDP The second-quarter GDP report is set to reveal noteworthy developments in the U.S. economy, signaling a moderate recovery in output. Recent estimates, compiled from various nowcasts, suggest an anticipated growth of 1.7% in GDP for this period. Current Economic Outlook This projection remains steady from earlier...
Continue Reading